View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Catalent

AsiaPacific Region Studies, Common Clinical Supply Challenges

Free White Paper

AsiaPacific Region Studies, Common Clinical Supply Challenges

By Catalent

AsiaPacific Region Studies, Common Clinical Supply Challenges

By Catalent
Enter your details to receive the free paper:

The number of clinical trials in the Asia-Pacific (APAC) region is growing as sponsors tap into expanding pharmaceutical market.

In many APAC countries, trials are often the only avenue available to patients to receive treatment. Patient compliance is generally very high. In addition, an overall growing level of sophistication within the region has led to improvements in data collection accuracy and increased intellectual property protection.

Challenges associated with conducting studies in this region can and do vary by country and whether the study sponsor is a local company or not. Unlike well-established clinical trial regions such as Europe, the APAC region is a collection of independent countries each with its own infrastructure limitations, clinical supply quality standards, regulations, and protocols. This means that the logistics involved to get clinical supplies to the right place at the right time within the region can be quite complex and is perhaps one of the most significant challenges that must be overcome.

Download to find out more.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology